Skip to main content
Isaac Francis Photo
Isaac Francis

Isaac Francis

GrafaFinance Journalist

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.

Articles by Isaac Francis

Grafa
Health

Citius Oncology reports positive Phase 1 data for LYMPHIR-Pembrolizumab combo

Citius Oncology (NASDAQ:CTOR) reported positive topline results on Tuesday from an investigator-initiated Phase 1 clinical trial evaluating its flagship immunotherapy, LYMPHIR (denileukin diftitox-cxdl), in combination with Merck’s pembrolizumab (Keytruda).

Read more: Citius Oncology reports positive Phase 1 data for LYMPHIR-Pembrolizumab combo